ABVC BioPharma, Inc. Profile Avatar - Palmy Investing

ABVC BioPharma, Inc.

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for…

Biotechnology
US, Fremont [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

ABVC BioPharma, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ABVC's Analysis
CIK: 1173313 CUSIP: 00091F106 ISIN: US00091F3047 LEI: - UEI: -
Secondary Listings
ABVC has no secondary listings inside our databases.